(2R,6R)-Hydroxynorketamine a Novel Therapeutic Analgesic for the Treatment of Neuropathic Pain: A Randomized Double Blind Cross-Over Trial.

Phase: PHASE1, PHASE2 | Sponsor: Rush University Medical Center | Compound: Ketamine

Status

recruiting

Institution

Rush University Medical Center

Start date

2024-09-19

End date

2026-12-01

Registry ID

NCT05864053

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.